Home / CHF / Santhera Reports 2020 Annual Results

Santhera Reports 2020 Annual Results

Santhera Pharmaceuticals (SIX: SANN) announces theCompany’s audited financial results for 2020 and reports on progress in advancing its leadcompound for the treatment of Duchenne muscular dystrophy …
Read Full Story at source (may require registration)